Plain-English translation of NCT07528027 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a Phase III trial testing a medication called to see if it works better than a placebo (a pill with no active ingredient) at lowering blood pressure. You'll be randomly assigned to receive either the medication or the placebo, and neither you nor the research team will know which one you're getting. The study focuses on people who have high blood pressure and are also overweight or obese.
Many people with high blood pressure who are also overweight or obese struggle to control their blood pressure with existing treatments. This trial is designed to see whether this new treatment offers a better way to help manage blood pressure in this specific group of patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either or a placebo daily. The study involves multiple visits to the clinic where your blood pressure will be measured and monitored. You'll be one of approximately 648 participants enrolled across multiple sites, and the research team will track how well the medication controls your blood pressure compared to the placebo group over the course of the trial.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China